Picture of Nevro logo

NVRO Nevro News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapTurnaround

Nevro Corp expected to post a loss of 86  cents a share - Earnings Preview

* Nevro Corp  NVRO.N   NVRO.K  is expected to show a fall in
quarterly revenue when it reports  results on February 23. 
    * The Redwood City California-based  company is expected to
report
 a 8.6% decrease in revenue to $100.26 million from $109.73
million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Nevro Corp is for a
loss
of 86 cents per share. For the same quarter last year, the
company reported a loss of 21 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 10
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Nevro Corp
is
$97​, about 33% above​ its last closing price of $64.98. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.88       -0.87      -0.86     Beat    0.7
 Jun. 30 2021  -0.73       -0.73      -0.62     Beat    15.4
 Mar. 31 2021  -0.87       -0.84      -0.85     Missed  -1.6​
 Dec. 31 2020  -0.35       -0.33      -0.21     Beat    35.5
 ​​Sep.        -0.56       -0.59      -0.29     Beat    50.7
 30 2020                                                
 Jun. 30 2020  -1.61       -1.62      -1.21     Beat    25.3​
 Mar. 31 2020  -1.03       -0.99      -0.78     Beat    21.5
 Dec. 31 2019  -0.60       -0.62      -0.44     Beat    29.4
 This summary was machine generated February 22 at 03:02 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Nevro

See all news